CN107822991A - A kind of feminine care wet tissue of bacteriostatic and disease prevention - Google Patents
A kind of feminine care wet tissue of bacteriostatic and disease prevention Download PDFInfo
- Publication number
- CN107822991A CN107822991A CN201711259806.2A CN201711259806A CN107822991A CN 107822991 A CN107822991 A CN 107822991A CN 201711259806 A CN201711259806 A CN 201711259806A CN 107822991 A CN107822991 A CN 107822991A
- Authority
- CN
- China
- Prior art keywords
- wet tissue
- feminine care
- care wet
- bacteriostatic
- decoction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/718—Coptis (goldthread)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0208—Tissues; Wipes; Patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/37—Extraction at elevated pressure or temperature, e.g. pressurized solvent extraction [PSE], supercritical carbon dioxide extraction or subcritical water extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/805—Corresponding aspects not provided for by any of codes A61K2800/81 - A61K2800/95
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Alternative & Traditional Medicine (AREA)
- Birds (AREA)
- Medical Informatics (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The present invention relates to a kind of feminine care wet tissue of bacteriostatic and disease prevention, it is prepared by the method comprised the following steps:(1) rhizoma atractylodis, the coptis, folium eucalypti and peppermint are taken respectively, are dried, are mixed after crushing, obtain mixed material;(2) CO 2 fluid of the mixed material by the use of ethanol water as entrainer is subjected to supercritical extract, obtains extract;(3) extract is diluted with the solvent being made up of ethanol and propane diols, takes filtrate after filtering, obtain bacteriostatic and disease prevention decoction;(4) decoction is attached in base fabric, produced.The feminine care wet tissue of bacteriostatic and disease prevention provided by the invention can prevent bacterium infection of the women caused by private parts is unclean, so as to prevent the diseases such as urethral system infection, bacillary, mycotic, trichomonas vaginitis and nonspecific vaginitis;And stability is good, still there is good fungistatic effect after long-term placement, there is extensive market application value.
Description
Technical field
The present invention relates to female article field, and in particular to a kind of feminine care wet tissue its preparation method of bacteriostatic and disease prevention.
Background technology
Women goes to toilet, and substitutes toilet paper with napkin, is easy to cause infection, is allowed to suffer from urethral system infection, bacillary, mould
The diseases such as property, trichomonas vaginitis and nonspecific vaginitis.These diseases are that the common disease of women, frequently-occurring disease are because of private parts
Caused by unclean, so, pudendum cleaning is kept to ensureing that body of women health is very critically important, especially before menstrual period or sexual intercourse
Afterwards, it is even more important.
Patent document CN102697671A discloses a kind of liquid medicine for wet tissue of bacteriostatic and disease prevention and preparation method thereof, the wet tissue medicine
The active component of water contains the composition of following parts by weight:Atractylis oil 0.1-5 parts, jamaicin 0.01-0.5 parts, eucalyptus oil 0.01-
0.5 part, borneol 0.01-0.05 parts, menthol 0.01-0.5 parts.Although the wet tissue that the patent provides has bacteriostatic and disease prevention effect,
To skin and vaginal mucosa without any excitant and side effect.With the patent similarly, most of existing feminine hygiene articles
It is concerned only with prevention or therapeutic effect in itself, and the stability of product is closed when in use, in the case of especially long-term placement to product
Note less, cause have certain difficulty in actual market popularization practical.
The content of the invention
A kind of it is an object of the present invention to the defects of overcoming prior art, there is provided the feminine care wet tissue of bacteriostatic and disease prevention.By
Contain liquid component in wet tissue, place easily and occur going bad so as to influence the antibacterial of wet tissue in the case where being added without preservative
Effect, wet tissue provided by the invention to raw material extracting method by optimizing, so as to true in the case where being not added with preservative
Protecting products obtained therefrom has good stability.
Specifically, the invention provides a kind of feminine care wet tissue of bacteriostatic and disease prevention, the method by comprising the following steps
It is prepared:
(1) rhizoma atractylodis, the coptis, folium eucalypti and peppermint are taken respectively, are dried, are mixed after crushing, obtain mixed material;
(2) CO 2 fluid of the mixed material by the use of ethanol water as entrainer is subjected to supercritical extract,
Obtain extract;
(3) extract is diluted with the solvent being made up of ethanol and propane diols, takes filtrate after filtering, obtain bacteriostatic and disease prevention medicine
Liquid;
(4) decoction is attached in base fabric, produced.
The present invention obtains extract using carbon dioxide supercritical extraction.By supercritical carbon dioxide and material to be separated
Contact, make it that selectively polarity size, boiling point the height composition different with molecular size range be extracted successively.Due to
The extracting object of the present invention is compound, therefore in extraction, the extraction of traditional Chinese medicine ingredients promotes other Chinese medicines due to the effect of dissolving each other
The extraction of composition, and active ingredient is highly concentrated, impurity is few, and appearance color is preferable, has collaboration supplementary result.It is of the invention abundant
The characteristic of each component in compound is considered, selects entrainer to carry out assisted extraction, so as to improve the selectivity of supercritical fluid, with
Ensure that the target product of the present invention can be proposed farthest, while prevention effect is improved, the hair beyond the present invention
Existing, the extract obtained by said extracted method has good stability after being prepared into wet tissue, has extremely strong market should
With value.
The present invention is by largely putting into practice discovery, when the entrainer is the ethanol water of volumetric concentration 70~90%,
Optimal extraction effect can be obtained, and gained wet tissue product has optimal stability.The preferably entrainer of the invention
Dosage is the 1~10% of the mixed material quality.As the present invention preferred scheme, the carbon dioxide supercritical extraction
Pressure is 20~40Mpa, and temperature is 30~50 DEG C.
The solvent that the present invention uses is formed by ethanol and mixed with propylene glycol.The present invention by largely putting into practice discovery, using by
Both solvent mixed is diluted to the extract, can make the excitant in extraction process while being extracted
Impurity sedimentation that is strong and influenceing stable effective ingredients, is then removed by follow-up settling step, so as to further improve
The stability of wet tissue product.As the preferred scheme of the present invention, the solvent is by ethanol and propane diols with volume ratio 1~2:5~7
Mix.
The degree of step (3) described dilution can realize that preventing and treating and avoids menstruation infection effect with what this area was appreciated that
Overstimulation is advisable, and in order to balance using effect and skin irritation, the extract is preferably diluted to former extraction by the present invention
Take 70~90 times that liquid accumulates.
In order to improve market acceptance, the present invention adds natural perfume material or artificial flavors before filtration;Preferably, the day
Right one or more of the spices in elscholtiza, borneol, oriental wormwood, peppermint, yellow wormwood artemisia;The artificial flavors be selected from plants essential oil and/
Or chemical synthesis essence, the plants essential oil are selected from Chinese torreya essential oil, mother chrysanthemum flower essential oil, daphne odera essential oil, pinecone essential oil, argy wormwood
One or more in oil, thyme essential oil, eucalyptus quintessence oil, tea tree ethereal oil and camphor tree essential oil.
The base fabric is selected from non-woven fabrics or wet-strength paper.Before adhering liquid medicine, the base fabric first carry out it is suitably sized, so
After carry out sterilization treatment.
Attachment of the present invention refers to soak base fabric with the decoction or the decoction is sprayed in base fabric.The spraying
Specially:After carrying out atomization process to the decoction, high-pressure injection is in base fabric.
As a preferred embodiment of the present invention, the raw material is preferably the combination of following parts by weight:Rhizoma atractylodis 20~30
1~5 part of part, 10~30 parts of the coptis, 5~15 parts of folium eucalypti and peppermint.
In actual applications, the wet tissue should be independent packaging, to ensure using health.
The feminine care wet tissue of bacteriostatic and disease prevention provided by the invention can prevent bacterium sense of the women caused by private parts is unclean
Dye, so as to prevent the diseases such as urethral system infection, bacillary, mycotic, trichomonas vaginitis and nonspecific vaginitis;It is and steady
It is qualitative good, still there is good fungistatic effect after long-term placement, there is extensive market application value.
Embodiment
Following examples are used to illustrate the present invention, but are not limited to the scope of the present invention.
Embodiment 1
A kind of feminine care wet tissue of bacteriostatic and disease prevention is present embodiments provided, is prepared by the following method:
(1) difference rhizoma atractylodis 25kg, coptis 20kg, folium eucalypti 10kg, peppermint 3kg, dry, mixed after crushing, obtain mixed material;
(2) using the mixed material, by the use of the ethanol water of concentration 70% as entrainer, (dosage of entrainer is described
The CO 2 fluid 10%) of mixed material quality, supercritical extract is carried out at being 40 DEG C in 30Mpa, temperature, must be extracted
Liquid;
(3) with ethanol and propane diols with volume ratio 1.5:The extract is diluted to former extraction by 6 solvents mixed
80 times of liquid product, take filtrate, produce bacteriostatic and disease prevention decoction after filtering;
(4) high-pressure injection produces wet tissue by cutting, in the base fabric of sterilizing after the decoction being carried out into atomization process,
Every wet tissue carries out independent packaging.
Embodiment 2
Compared with Example 1, differ only in, the step (1), (2) are specially:
(1) difference rhizoma atractylodis 20kg, coptis 10kg, folium eucalypti 5kg, peppermint 1kg, dry, mixed after crushing, obtain mixed material;
(2) using the mixed material, by the use of the ethanol water of concentration 70% as entrainer, (dosage of entrainer is described
The CO 2 fluid 1%) of mixed material quality, supercritical extract is carried out at being 30 DEG C in 20Mpa, temperature, obtains extract.
Embodiment 3
Compared with Example 1, differ only in, the step (1), (2) are specially:
(1) difference rhizoma atractylodis 30kg, coptis 30kg, folium eucalypti 15kg, peppermint 5kg, dry, mixed after crushing, obtain mixed material;
Using the mixed material, by the use of the ethanol water of concentration 90% as entrainer, (dosage of entrainer is the mixing
The CO 2 fluid 10%) of material quality, supercritical extract is carried out at being 50 DEG C in 40Mpa, temperature, obtains extract.
Embodiment 4
Compared with Example 1, differ only in, the solvent that the step (3) uses is by ethanol and propane diols with volume ratio
For 1:10 mix.
Embodiment 5
Compared with Example 1, differ only in, the solvent that the step (3) uses is by ethanol and propane diols with volume ratio
For 1:2 mix.
Comparative example 1
Compared with Example 1, differ only in, the solvent of step (3) described dilution is 70% ethanol water.
Comparative example 2
Compared with Example 1, differ only in, the formula referenced patent document CN102697671A embodiments 2 of liquid medicine are public
The formula opened, is specifically comprised:Atractylis oil 19g, jamaicin 0.5g, eucalyptus oil 0.8g, borneol 0.13g, peppermint oil 1.5g.(close
Count 21.93g)
Preparation method:
1) each composition is weighed according to proportioning, it is standby;
2) Atractylis oil for weighing formula ratio (prepares) 19g according to the method for embodiment 1, is dissolved in 500g 95% ethanol,
Fully after dissolving, bottom white insoluble liq is removed with separatory funnel, the export of upper strata alcoholic solution, obtains rhizoma atractylodis oleyl alcohol, it is standby
With;
3) peppermint, borneol are well mixed, are separately added into jamaicin, rhizoma atractylodis oleyl alcohol, eucalyptus oil and 2500g glycerine,
Well mixed, the ethanol constant volume for adding 95% arrives 10kg, and ultrasonic wave dissolves, to pink colour clear solution, produced.
Passing through according to high-pressure injection after the decoction is carried out into atomization process with the step of embodiment 1 (4) identical mode
Cut, in the base fabric of sterilizing, produce wet tissue, every wet tissue carries out independent packaging.
Experimental example:Long-term bacteriostatic experiment
After the wet tissue that each embodiment and comparative example are provided is placed 0,2,6 month at normal temperatures respectively, bacteriostasis rate is tested, it is empty
White control is undressed blank sterilizing non-woven fabrics.Experimental strain:Staphylococcus aureus, Candida albicans, Escherichia coli,
Pseudomonas aeruginosa, hemolytic streptococcus;Specific experiment step refers to《15979-2002 disposable sanitary articles sanitary standards》Rule
It is fixed.As a result as shown in table 1~3.
Table 1:0 month bacteriostasis rate (%)
Staphylococcus aureus | Candida albicans | Escherichia coli | Pseudomonas aeruginosa | Hemolytic streptococcus | |
Blank control | 0 | 0 | 0 | 0 | 0 |
Embodiment 1 | 99.7 | 99.6 | 99.1 | 99.5 | 99.3 |
Embodiment 2 | 99.0 | 99.1 | 99.6 | 99.5 | 99.4 |
Embodiment 3 | 99.4 | 99.8 | 99.6 | 99.4 | 99.0 |
Embodiment 4 | 98.0 | 98.2 | 98.4 | 98.9 | 98.2 |
Embodiment 5 | 98.9 | 99.2 | 99.0 | 98.5 | 99.0 |
Comparative example 1 | 96.5 | 97.9 | 96.2 | 97.2 | 98.1 |
Comparative example 2 | 98.0 | 98.2 | 97.9 | 98.9 | 99.0 |
Table 2:2 months bacteriostasis rates (%)
Staphylococcus aureus | Candida albicans | Escherichia coli | Pseudomonas aeruginosa | Hemolytic streptococcus | |
Blank control | 0 | 0 | 0 | 0 | 0 |
Embodiment 1 | 99.1 | 99.1 | 98.5 | 99.0 | 98.9 |
Embodiment 2 | 98.5 | 98.8 | 99.0 | 99.2 | 99.0 |
Embodiment 3 | 99.2 | 99.1 | 99.0 | 99.0 | 98.9 |
Embodiment 4 | 97.5 | 97.6 | 98.0 | 98.2 | 97.5 |
Embodiment 5 | 97.9 | 98.8 | 98.5 | 97.5 | 98.0 |
Comparative example 1 | 95.9 | 96.4 | 95.5 | 96.1 | 96.8 |
Comparative example 2 | 95.3 | 97.6 | 95.8 | 97.6 | 95.8 |
Table 3:6 months bacteriostasis rates (%)
From result above, wet tissue provided by the invention has good fungistatic effect, and is being not added with preservative
In the case of through long-term biocidal property of placing keep stable.
Although above the present invention is made to retouch in detail with general explanation, embodiment and experiment
State, but on the basis of the present invention, it can be made some modifications or improvements, this is apparent to those skilled in the art
's.Therefore, these modifications or improvements without departing from theon the basis of the spirit of the present invention, are belonged to claimed
Scope.
Claims (10)
1. the feminine care wet tissue of a kind of bacteriostatic and disease prevention, it is characterised in that be prepared by the method comprised the following steps:
(1) rhizoma atractylodis, the coptis, folium eucalypti and peppermint are taken respectively, are dried, are mixed after crushing, obtain mixed material;
(2) CO 2 fluid of the mixed material by the use of ethanol water as entrainer is subjected to supercritical extract, must extracted
Take liquid;
(3) extract is diluted with the solvent being made up of ethanol and propane diols, takes filtrate after filtering, obtain bacteriostatic and disease prevention decoction;
(4) decoction is attached in base fabric, produced.
2. feminine care wet tissue according to claim 1, it is characterised in that the entrainer is volumetric concentration 70~90%
Ethanol water.
3. feminine care wet tissue according to claim 1 or 2, it is characterised in that the dosage of the entrainer is described mixed
Close the 1~10% of material quality.
4. the feminine care wet tissue according to claims 1 to 3 any one, it is characterised in that the carbon dioxide is super to be faced
The pressure of boundary's extraction is 20~40Mpa, and temperature is 30~50 DEG C.
5. feminine care wet tissue according to claim 1, it is characterised in that step (3) solvent is by ethanol and the third two
Alcohol is with volume ratio 1~2:5~7 mix.
6. feminine care wet tissue according to claim 1, it is characterised in that add natural perfume before step (3) described filtering
Material or artificial flavors;
Preferably, one or more of the natural perfume material in elscholtiza, borneol, oriental wormwood, peppermint, yellow wormwood artemisia;The artificial fragrant
Material is selected from plants essential oil and/or chemical synthesis essence, and the plants essential oil is selected from Chinese torreya essential oil, mother chrysanthemum flower essential oil, daphne odera essence
One or more in oil, pinecone essential oil, mugwort oil, thyme essential oil, eucalyptus quintessence oil, tea tree ethereal oil and camphor tree essential oil.
7. feminine care wet tissue according to claim 1, it is characterised in that the base fabric is selected from non-woven fabrics or wet-strength paper.
8. feminine care wet tissue according to claim 7, it is characterised in that the attachment refers to soak base with the decoction
The decoction is sprayed in base fabric by cloth.
9. feminine care wet tissue according to claim 8, it is characterised in that the spraying is specially:The decoction is carried out
After atomization process, high-pressure injection is in base fabric.
10. the feminine care wet tissue according to claim 1~9 any one, it is characterised in that in step (1), take rhizoma atractylodis
20~30 parts, 10~30 parts of the coptis, 5~15 parts of folium eucalypti, 1~5 part of peppermint.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711259806.2A CN107822991A (en) | 2017-12-04 | 2017-12-04 | A kind of feminine care wet tissue of bacteriostatic and disease prevention |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711259806.2A CN107822991A (en) | 2017-12-04 | 2017-12-04 | A kind of feminine care wet tissue of bacteriostatic and disease prevention |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107822991A true CN107822991A (en) | 2018-03-23 |
Family
ID=61641174
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201711259806.2A Pending CN107822991A (en) | 2017-12-04 | 2017-12-04 | A kind of feminine care wet tissue of bacteriostatic and disease prevention |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107822991A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107753349A (en) * | 2017-12-04 | 2018-03-06 | 株洲千金药业股份有限公司 | A kind of feminine care wet tissue for preventing and treating menstruation infection |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106727094A (en) * | 2015-11-20 | 2017-05-31 | 青岛华南盛源果业有限公司 | A kind of wet tissue for ladies only |
-
2017
- 2017-12-04 CN CN201711259806.2A patent/CN107822991A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106727094A (en) * | 2015-11-20 | 2017-05-31 | 青岛华南盛源果业有限公司 | A kind of wet tissue for ladies only |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107753349A (en) * | 2017-12-04 | 2018-03-06 | 株洲千金药业股份有限公司 | A kind of feminine care wet tissue for preventing and treating menstruation infection |
CN107753349B (en) * | 2017-12-04 | 2021-01-26 | 株洲千金药业股份有限公司 | Female nursing wet tissue for preventing and treating menstrual infection |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101940224B (en) | Plant bacteriostatic composition and application thereof | |
CN102614102B (en) | Dandruff-removing medicinal composition and preparation method thereof | |
CN102697671B (en) | Bacterium and disease prevention wet wipe liquid medicament and preparation method thereof | |
CN104127779B (en) | A kind of Chinese herb compound washing lotion of anti-inflammation and preparation method thereof | |
CN107952104A (en) | A kind of feminine hygiene articles for preventing menstruation infection and preparation method thereof | |
JP5690102B2 (en) | Composition for preventing and treating urological diseases and method for producing the same | |
CN107753998A (en) | A kind of feminine hygiene articles of bacteriostatic and disease prevention and preparation method thereof | |
KR102133101B1 (en) | A Feminine cleanser composition comprising imperata cylindrica leaf and artemisia princeps | |
CN105148288A (en) | Cyclodextrin-and-modified-cyclodextrin-assisted method for extracting effective ingredients of traditional Chinese medicinal materials | |
CN104984196B (en) | A kind of bactericidal composition containing favus skin and preparation method thereof | |
KR100847478B1 (en) | Composition for functional soap comprising gold or silver nanoparticle and extraction polymer of black nightshade as effective ingredients, and production method thereof | |
CN107753349A (en) | A kind of feminine care wet tissue for preventing and treating menstruation infection | |
CN107753999A (en) | A kind of feminine hygiene articles for preventing and treating puerperal infection and preparation method thereof | |
CN107822991A (en) | A kind of feminine care wet tissue of bacteriostatic and disease prevention | |
CN107822992A (en) | A kind of feminine care wet tissue for preventing and treating puerperal infection | |
CN106110374A (en) | Chinese medicinal herbal plant liquid cotton gauze sanitary towel and preparation method thereof | |
CN106390182A (en) | Sanitary napkin with antibacterial natural fiber surface layer and manufacturing method of sanitary napkin with antibacterial natural fiber surface layer | |
CN107754000A (en) | A kind of feminine care non-woven fabrics of bacteriostatic and disease prevention and its application | |
CN105232824A (en) | Tea oil composition and preparing method and application thereof | |
CN107929801A (en) | A kind of feminine care non-woven fabrics for preventing menstruation infection and its application | |
CN106798701A (en) | A kind of Chinese medicine bath cream for preventing and treating pruitus and preparation method thereof | |
CN102846870B (en) | External anti-inflammatory drug from the Miao nationality and production process thereof | |
CN107088235A (en) | The application of soapberry and its extract in amenities is prepared | |
CN102462644A (en) | Sterilizing skin-cleansing agent and production process thereof | |
CN108743465A (en) | Traditional Chinese medicine gel composition and its preparation method and application |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180323 |